Skip to main content
. 2017 Jan 17;36:29–33. doi: 10.1007/8904_2016_32

Table 3.

Overview of high-risk studies focusing on symptoms compatible with MPS

Number of screened persons MPS MPS I MPS II MPS VI
Lukacs et al. (2014) 6.1% 3.3% 4.8%
Lukacs (2013) 602 8% 5% 4%
Coelho et al. (1997) 9,901 8.3%
Ly-Pen et al. (2010) 12 16.7%
Davis and Vedanarayanan (2014) 13 7.7%
Potulska-Chromik et al. (2014) 11 9.1%
Wang et al. (2006) 58 1.7%